PDC News & Events

Perpetuals.com launched UpsideOnly, a "risk-free" trading and market prediction platform that uses a proprietary AI algorithm combined with crowd intelligence to ensure users never lose money. The company said, "The problem is real: retail traders lose more than $12B a year to platforms structurally positioned against them. UpsideOnly solves that problem by creating a powerful human-AI collaboration that brings profit to both Perpetuals and its users. UpsideOnly is built on the simple idea that AI gets smarter when it learns from human traders. As users make predictions across global financial markets such as stocks, cryptocurrencies and commodities, the algorithm folds their insights into its own analysis, producing incredibly accurate trading signals. UpsideOnly uses those signals to make market trades with its own capital and shares the winnings with the users whose predictions helped shape them. Powering UpsideOnly is the proprietary patent-pending BayesShield AI, which is trained on more than 22 billion executed retail trades, one of the largest trading datasets ever used to train an AI model. The BayesShield algorithm learns from user predictions across global markets, combining human insight with machine-scale pattern recognition to produce trading signals neither could generate alone. UpsideOnly lets users benefit from trading gains while eliminating risk by trading exclusively with the company's own capital - users never put up their own money for trading. This ensures users cannot incur losses. Users make predictions about where global equity, commodity, forex, and crypto markets are heading without ever placing a real trade themselves. BayesShield analyzes each person's prediction, and when the algorithm indicates that prediction is likely to be successful, UpsideOnly executes a trade with its own capital. If no trade is made, or if a trade is made and loses, the user loses nothing. If the trade wins, the company shares the profit with the user. UpsideOnly also offers additional ways for users to win money based on their overall performance for the week and month, among others...No deposit is required to make a prediction and win money on UpsideOnly, but in order to reduce the presence of bots, users who choose to put down a refundable deposit of $1 or more will receive higher payouts. Users who make even small deposits are less likely to be bots and more likely to make considered and reliable predictions. The deposit is not a trading stake and is never used for trading. The deposit is held safely in U.S. Treasury Bills in an external account by a separate U.S.-based fiduciary and can be withdrawn by the user at any time."

Perpetuals.com has filed a U.S. patent application covering BayesShield AI, a system that identifies which AI model or human expert performs best for a specific decision, in real time. "For a decade, AI progress has been measured by which model has the best benchmark average. The agentic era has exposed that this metric doesn't predict production performance; McKinsey, Gartner, and Deloitte are all reporting the same gap. The next edge in AI isn't a single model that wins on average. It's a system that knows which model, or which expert, will win in the decision in front of you," said Patrick Gruhn, CEO of Perpetuals. "That's what we are patenting. And it's already running our products today."

Perpetuals.com announced the extension of its proprietary BayesShield AI technology into healthcare. BayesShield Clinical applies the same patent-pending methodology the company developed to predict trading outcomes to a new domain: identifying which physicians in hospitals and clinics are the most accurate at diagnosing specific types of cases to ensure patients get the best health outcomes. BayesShield Clinical is designed for hospitals, clinics, and health systems. It does not diagnose patients or replace physician judgment. Instead, it strips away behavioral biases, applying statistical methods to identify patterns of diagnostic strength across specific case types. Hospitals and other health care providers can use these insights for optimized case routing, second-opinion protocols, and training program design. Financial markets and clinical medicine share a common analytical problem: decisions made under uncertainty, where skill is obscured by noise, variable conditions, and behavioral bias. The company believes the same approach that identifies performance patterns in financial markets can reveal them in clinical decision-making. Perpetuals has partnered with the European Institute of Management to support the clinical implementation of BayesShield Clinical. Under the arrangement, Perpetuals provides the software platform while EIM works directly with partner hospitals and clinics to manage pilot deployment, trial design, and academic oversight. EIM's PhD in Healthcare Studies program will serve as the academic collaboration for the clinical pilots, with doctoral candidates contributing to the study design and analysis of outcomes.

Perpetuals.com announced the execution of a strategic licensing agreement with the German University of Digital Science for the integration of the company's proprietary BayesShield AI predictive intelligence platform. German UDS will license BayesShield AI for deployment across its research centers and digital learning infrastructure, including its Research Center for Artificial Intelligence, Research Center for Cybersecurity, and Research Center for Digital Transformations. German UDS will integrate BayesShield AI into its curriculum as a live case study and applied research platform across multiple graduate programs, including its M.Sc. in Applied AI, M.Sc. in Cybersecurity, MBA in Financial Technology, and MBA in Digital Technologies. Students and faculty can leverage BayesShield's probabilistic AI models, trained on 11.7 billion retail trades and more than 1 million unique user histories, to analyze real-world trading patterns, conduct research on retail investor behavior, and develop next-generation risk management frameworks.